Lido Advisors, LLC Sc Pharmaceuticals Inc. Transaction History
Lido Advisors, LLC
- $25.9 Billion
- Q2 2025
A detailed history of Lido Advisors, LLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Lido Advisors, LLC holds 27,500 shares of SCPH stock, worth $155,925. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,500
Previous 24,000
14.58%
Holding current value
$155,925
Previous $63,000
65.08%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SCPH
# of Institutions
97Shares Held
32.6MCall Options Held
757KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million0.82% of portfolio
-
Rubric Capital Management LP New York, NY4.6MShares$26.1 Million0.4% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX3.54MShares$20.1 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.15MShares$12.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$10.4 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...